openPR Logo
Press release

Retinal Vein Occlusion (RVO) Market Size Worth USD 4.65 Billion 2032 | Emergen Research

04-18-2024 04:11 PM CET | Health & Medicine

Press release from: Emergen Research

Retinal Vein Occlusion (RVO) Market

Retinal Vein Occlusion (RVO) Market

The global Retinal Vein Occlusion (RVO) market size was USD 2.46 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.7% during the forecast period. A recent market research report has shed light on the flourishing trajectory of the global Retinal Vein Occlusion (RVO) treatment market. The report attributes this growth to various factors including the rising prevalence of diabetes and atherosclerosis, coupled with the development of novel drugs aimed at addressing this condition. Additionally, increased Research and Development (R&D) activities, presence of a robust pipeline, and drug approvals have contributed to the market's expansion.

Retinal Vein Occlusion, characterized by the blockage of small veins carrying blood away from the retina, can lead to sudden vision loss. The severity and type of disorder determine the choice of treatment, which typically involves anti-vascular endothelial growth factor injections or focal laser procedures.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2839

Key Drivers of the Retinal Vein Occlusion Market

The market has seen significant growth driven by technological advancements such as Artificial Intelligence (AI), Internet of Things (IoT), and Machine Learning (ML). These innovations promise faster, safer, and more accurate procedures, leading to improved patient outcomes.

Challenges and Restraints

Despite the promising advancements, high equipment costs and stringent government regulations pose challenges to market growth. Affordability remains a concern, particularly for regions with limited resources.

Segment Insights

Disease Type Segmentation:
• The Central Retinal Vein Occlusion (CRVO) segment holds the largest market share due to a rising pipeline of drugs specifically designed for its treatment.
• The Branch Retinal Vein Occlusion (BRVO) segment is expected to witness steady growth, driven by increased focus on treatment options.
Treatment Segmentation:
• Anti-vascular Endothelial Growth Factor (Anti-VEGF) treatment dominates the market, offering breakthrough solutions for Retinal Vein Occlusion, including age-related macular degeneration.
• Corticosteroid drugs are also gaining traction, targeting various aspects of Retinal Vein Occlusion pathophysiology.

End-Use Segmentation:

• Retail pharmacies are expected to lead the market, providing enhanced accessibility to treatment options and medications. Patient education and guidance offered by these pharmacies further contribute to their growth.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @
https://www.emergenresearch.com/request-discount/2839

Retinal Vein Occlusion Top Companies and Competitive Landscape

The global Retinal Vein Occlusion market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective Retinal Vein Occlusion solutions.

Some major players included in the global Retinal Vein Occlusion market report are:

• Taiwan Liposome Company, Ltd.
• Outlook Therapeutics, Inc.
• Chugai Pharmaceutical Co., Ltd.
• Hoffmann-La Roche Ltd.
• CalciMedica Inc.
• Kodiak Sciences Inc.
• Pfizer Inc.
• AbbVie Inc.
• Lumenis
• Aerie Pharmaceuticals Inc.

Retinal Vein Occlusion Latest Industry News

• In January 2022, Mentor Worldwide LLC (a subsidiary of the Johnson & Johnson Medical Devices Companies) announced that Food and Drug Administration (FDA) had approved the MENTOR MemoryGel BOOST breast implant for breast augmentation and breast reconstruction. This product has helped the company to enhance its product portfolio of aesthetics in the U.S. market.

• In December 2021, Allergan Aesthetics, part of AbbVie, acquired a medical technology company, Soliton, Inc. This acquisition helped the company to strengthen its portfolio of non-invasive body contouring treatments.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2839

Retinal Vein Occlusion Market Segment Analysis

For the purpose of this report, Emergen Research has segmented the global Retinal Vein Occlusion market on the basis of disease type, treatment, condition, end-use, and region:

• Disease Type Outlook (Revenue, USD Billion; 2019-2032)
o Central Retinal Vein Occlusion (CRVO)
o Branch Retinal Vein Occlusion (BRVO)
• Treatment Outlook (Revenue, USD Billion; 2019-2032)
o Anti-vascular Endothelial Growth Factor (Anti-VEGF)
o Corticosteroid drugs
o Laser therapy
o Others
• Condition Outlook (Revenue, USD Billion; 2019-2032)
o Ischemic
o Non ischemic
• End-Use Outlook (Revenue, USD Billion; 2019-2032)
o Hospital & clinics
o Retail pharmacy
o Others
• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
o Europe
1. Germany
2. France
3. UK
4. Italy
5. Spain
6. Benelux
7. Russia
8. Rest of Europe
o Asia Pacific
1. China
2. Japan
3. South Korea
4. India
5. ASEAN Countries
6. Oceania
7. Rest of APAC
o Latin America
1. Brazil
2. Mexico
3. Rest of LATAM
o Middle East & Africa
1. GCC Countries
2. Israel
3. Turkey
4. South Africa
5. Rest of Middle East & Africa

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/retinal-vein-occlusion-market

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinal Vein Occlusion (RVO) Market Size Worth USD 4.65 Billion 2032 | Emergen Research here

News-ID: 3468956 • Views:

More Releases from Emergen Research

Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Published by Emergen Research
Bacteriophage Market Size to Boost USD 65.67 Million By 2032 | CAGR 4.2% - Publi …
The global Bacteriophage Market size was USD 43.52 Million in 2022 and is expected to register a steady revenue CAGR of 4.2% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of antibiotic-resistant bacteria and rising demand for personalized medicine and investments and research activities for the production of bacteriophage based treatments and medications are key factors driving market revenue growth. Bacteriophages have been shown to be
Internet of Behaviors (IoB) Market Size to Boost USD 3,087.86 Billion By 2032 | CAGR 23.6% - Published by Emergen Research
Internet of Behaviors (IoB) Market Size to Boost USD 3,087.86 Billion By 2032 | …
The global Internet of Behaviors (IoB) market size is expected to reach USD 3.087.86 Billion in 2032 and register a steady revenue CAGR of 23.6% over the forecast period, according to the latest analysis by Emergen Research. Stringent regulations on the use of Internet of Behaviors (IoB) in various industries and technological advancements of big data analytics and IoB technology are key factors driving market revenue growth. The use and
Consumer Internet of Things (IoT) Market Size to Boost USD 334.78 Billion By 2032 | CAGR 13.9% - Published by Emergen Research
Consumer Internet of Things (IoT) Market Size to Boost USD 334.78 Billion By 203 …
The global Consumer Internet of Things (IoT) Market size is expected to reach USD 334.78 Billion in 2032 and register a revenue CAGR of 13.9% during the forecast period, according to the latest analysis by Emergen Research. Increasing adoption of smart devices and growing number of internet users is a major factor driving the market revenue growth. When using the Internet of Things for customer care, organizations can use the
Industrial Safety Market Size to Boost USD 12.33 Billion By 2032 | CAGR 6.8% - Published by Emergen Research
Industrial Safety Market Size to Boost USD 12.33 Billion By 2032 | CAGR 6.8% - P …
The Industrial Safety Market is experiencing robust growth, driven by the imperative need for workplace safety across various industries worldwide. Industrial safety encompasses a range of products, solutions, and services designed to protect workers, assets, and the environment from occupational hazards and accidents. With an increasing focus on compliance with stringent safety regulations, risk mitigation, and employee well-being, industries are investing in advanced safety technologies and practices. The market's expansion

All 5 Releases


More Releases for Retinal

Retinal Vein Occlusion Market : Information by Type (Branch Retinal Artery Occlu …
Retinal vein occlusion (RVO) causes permanent blindness. It is dominant in the geriatric population. However, it can also be found in people with leukemia, glaucoma, lymphoma, and multiple myeloma. Retinal vein occlusion is broadly categorized into central retinal artery occlusion (CRAO) and branch retinal vein occlusion (BRVO). Glaucoma is another such condition that damages optic nerves and causes retinal vein occlusion, which is becoming another point of concern across
What's driving the Retinal Implants Market Growth? Prominent Players: Second Sig …
An analysis of Retinal Implants market has been provided in the latest report added by Market Study Report that primarily focuses on the market trends, demand spectrum, and future prospects of this industry over the forecast period. Furthermore, the report provides a detailed statistical overview in terms of trends outlining the geographical opportunities and contributions by prominent industry share contenders. The global Retinal Implants market is valued at million
Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …
Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;
Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …
Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;
Global Retinal Implants Market 2018 - Centrasight, Retinal Implant, Boston Retin …
Eminent Market Reports, recently published a detailed market research study focused on the “Retinal Implants Market” across the global, regional and country level. The report provides 360° analysis of “Retinal Implants Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Retinal Implants on
Retinal Surgery Device Market, Global Forecast by Segments (Retinal Lasers, Vitr …
Renub Research report titled “Retinal Surgery Device Market, Global Forecast by Segments (Retinal Lasers, Vitrectomy Machines, Instruments, Tamponades, Retinal Laser Probes, Hemostasis, Light Pipes, Cryosurgery, Vitrectomy Packs, and Light source & others.) Companies (Alcon Laboratories, Inc., Carl Zeiss, Topcon Corporation, Valeant Pharmaceutical International Inc., Iridex Coporation, Ellex Medical Lasers, Escalon Medical, and Second Sight Medical Products Inc.)” studies the global retinal surgery device market. This 85 page report with 42